고현정 조교수
#신장병리#비뇨생식계병리#림프망내계병리
|
학력
2007 .09 ~ 2012 .02서울대학교 의학 박사
2000 .03 ~ 2006 .02서울대학교 의학 학사
2000 .03 ~ 2006 .02서울대학교 의학 학사
경력
2016 .03 ~ 현재서울아산병원 병리과 임상조교수
2013 .03 ~ 2016 .02서울아산병원 병리과 임상전임강사
2011 .03 ~ 2013 .02서울대학교병원 병리과 임상강사(전임의, 펠로우)
2007 .03 ~ 2011 .02서울대학교병원 병리과 전공의(레지던트)
2006 .03 ~ 2007 .02서울대학교병원 수련의(인턴)
2013 .03 ~ 2016 .02서울아산병원 병리과 임상전임강사
2011 .03 ~ 2013 .02서울대학교병원 병리과 임상강사(전임의, 펠로우)
2007 .03 ~ 2011 .02서울대학교병원 병리과 전공의(레지던트)
2006 .03 ~ 2007 .02서울대학교병원 수련의(인턴)
논문
Comparative analysis of PD-L1 expression between primary and metastatic pulmonary adenocarcinomas.
Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma.
Dishevelled segment polarity protein 3 (DVL3): a novel and easily applicable recurrence predictor in localised prostate adenocarcinoma.
Diverse Immunoprofile of Ductal Adenocarcinoma of the Prostate with an Emphasis on the Prognostic Factors.
Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy.
MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic
carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics.
Pellino 1 inactivates mitotic spindle checkpoint by targeting BubR1 for ubiquitinational degradation.
Prognostic Significance of Macroscopic Appearance in Clear Cell Renal Cell Carcinoma and Its Metastasis-Predicting Model.
Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering in the diagnosis of chronic active/acute antibody-mediated rejection.
Oncogenic microtubule hyperacetylation through BEX4-mediated sirtuin 2 inhibition.
PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung.
PELI1 expression is correlated with MYC and BCL6 expression and associated with poor prognosis in diffuse large B-cell lymphoma.
Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status.
Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.
Clinicopathological analysis of programmed cell death-1 and programmed cell death-ligand 1 expression in the tumor microenvironments of diffuse large B-cell lymphomas.
Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.
Immunoprofile-based subgrouping of urothelial bladder carcinomas for survival prediction.
MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.
Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Benign Indolent CD56-Positive NK-Cell Lymphoproliferative Lesion Involving Gastrointestinal Tract in an Adolescent.
Correlation between the size of the solid component on thin-section CT and the invasive component on pathology in small lung adenocarcinomas manifesting as ground-glass nodules.
Expression of toll-like receptor 2 and 4 is increased in the respiratory epithelial cells of chronic idiopathic interstitial pneumonia patients.
Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.
Hepatoid differentiation in renal cell carcinoma: a rare histologic pattern with clinical significance.
Sarcomatoid features, necrosis, and grade are prognostic factors in metastatic clear cell renal cell carcinoma with vascular endothelial growth factor-targeted therapy.
The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of age.
Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma.
Dishevelled segment polarity protein 3 (DVL3): a novel and easily applicable recurrence predictor in localised prostate adenocarcinoma.
Diverse Immunoprofile of Ductal Adenocarcinoma of the Prostate with an Emphasis on the Prognostic Factors.
Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy.
MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic
carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics.
Pellino 1 inactivates mitotic spindle checkpoint by targeting BubR1 for ubiquitinational degradation.
Prognostic Significance of Macroscopic Appearance in Clear Cell Renal Cell Carcinoma and Its Metastasis-Predicting Model.
Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering in the diagnosis of chronic active/acute antibody-mediated rejection.
Oncogenic microtubule hyperacetylation through BEX4-mediated sirtuin 2 inhibition.
PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung.
PELI1 expression is correlated with MYC and BCL6 expression and associated with poor prognosis in diffuse large B-cell lymphoma.
Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status.
Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.
Clinicopathological analysis of programmed cell death-1 and programmed cell death-ligand 1 expression in the tumor microenvironments of diffuse large B-cell lymphomas.
Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.
Immunoprofile-based subgrouping of urothelial bladder carcinomas for survival prediction.
MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.
Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Benign Indolent CD56-Positive NK-Cell Lymphoproliferative Lesion Involving Gastrointestinal Tract in an Adolescent.
Correlation between the size of the solid component on thin-section CT and the invasive component on pathology in small lung adenocarcinomas manifesting as ground-glass nodules.
Expression of toll-like receptor 2 and 4 is increased in the respiratory epithelial cells of chronic idiopathic interstitial pneumonia patients.
Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.
Hepatoid differentiation in renal cell carcinoma: a rare histologic pattern with clinical significance.
Sarcomatoid features, necrosis, and grade are prognostic factors in metastatic clear cell renal cell carcinoma with vascular endothelial growth factor-targeted therapy.
The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of age.
저서
저서 내용이 없습니다.
보도자료
진단 AI 개발…신장이식 거부반응 13분 만에 찾아낸다
https://health.chosun.com/site/data/html_dir/2019/04/29/2019042902439.html
https://health.chosun.com/site/data/html_dir/2019/04/29/2019042902439.html
포스팅
Epithelial-mesenchymal transition as a mechanism of acquired tyrosine kinase inhibitor resistance in clear cell renal cell carcinoma
Molecular Subgrouping and Prognosis Prediction Using Immunoprofile of Urothelial Carcinoma
Molecular Subgrouping and Prognosis Prediction Using Immunoprofile of Urothelial Carcinoma
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.